Depositions Repetitive In Celexa, Lexapro MDL, Forest Says

By Dani Kass (September 7, 2016, 3:14 PM EDT) -- Forest Laboratories Inc. on Tuesday asked a Massachusetts federal court not to make six former employees sit for depositions in multidistrict litigation accusing the company of misleading consumers about the efficacy of its drugs Celexa and Lexapro, arguing discovery has been extensive enough and most of them have already been questioned....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!